메뉴 건너뛰기




Volumn 85, Issue 8, 2014, Pages 860-865

Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; APOLIPOPROTEIN E; BETA1A INTERFERON; LIPOPROTEIN A; ANTIINFLAMMATORY AGENT; CHOLESTEROL; INTERFERON; LIPID; METHYLPREDNISOLONE;

EID: 84904183301     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-307106     Document Type: Article
Times cited : (35)

References (39)
  • 1
    • 51649096593 scopus 로고    scopus 로고
    • The genetics of clinical outcome in multiple sclerosis
    • Ramagopalan SV, Deluca GC, Degenhardt A, et al. The genetics of clinical outcome in multiple sclerosis. J Neuroimmunol 2008;201-202:183-99.
    • (2008) J Neuroimmunol , vol.201-202 , pp. 183-199
    • Ramagopalan, S.V.1    Deluca, G.C.2    Degenhardt, A.3
  • 3
    • 84885649688 scopus 로고    scopus 로고
    • Lipid profiles are associated with lesion formation over 24 months in interferon-beta treated patients following the first demyelinating event
    • Weinstock-Guttman B, Zivadinov R, Horakova D, et al. Lipid profiles are associated with lesion formation over 24 months in interferon-beta treated patients following the first demyelinating event. J Neurol Neurosurg Psychiatry 2013;84:1186-91.
    • (2013) J Neurol Neurosurg Psychiatry , vol.84 , pp. 1186-1191
    • Weinstock-Guttman, B.1    Zivadinov, R.2    Horakova, D.3
  • 4
    • 80053550020 scopus 로고    scopus 로고
    • Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis
    • Weinstock-Guttman B, Zivadinov R, Mahfooz N, et al. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J Neuroinflammation 2011;8:127.
    • (2011) J Neuroinflammation , vol.8 , pp. 127
    • Weinstock-Guttman, B.1    Zivadinov, R.2    Mahfooz, N.3
  • 5
    • 77950209814 scopus 로고    scopus 로고
    • Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis
    • Marrie RA, Rudick R, Horwitz R, et al. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology 2010;74:1041-7.
    • (2010) Neurology , vol.74 , pp. 1041-1047
    • Marrie, R.A.1    Rudick, R.2    Horwitz, R.3
  • 6
    • 81255135976 scopus 로고    scopus 로고
    • Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosis
    • Weinstock-Guttman B, Zivadinov R, Ramanathan M. Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosis. J Neurol Sci 2011;311:86-91.
    • (2011) J Neurol Sci , vol.311 , pp. 86-91
    • Weinstock-Guttman, B.1    Zivadinov, R.2    Ramanathan, M.3
  • 7
    • 84884812196 scopus 로고    scopus 로고
    • Interactions of serum cholesterol with anti-herpesvirus responses affect disease progression in clinically isolated syndromes
    • Weinstock-Guttman B, Horakova D, Zivadinov R, et al. Interactions of serum cholesterol with anti-herpesvirus responses affect disease progression in clinically isolated syndromes. J Neuroimmunol 2013;263:121-7.
    • (2013) J Neuroimmunol , vol.263 , pp. 121-127
    • Weinstock-Guttman, B.1    Horakova, D.2    Zivadinov, R.3
  • 8
    • 40749121688 scopus 로고    scopus 로고
    • The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment
    • DOI 10.1111/j.1463-1326.2007.00714.x
    • Andrikoula M, McDowell IF. The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment. Diabetes Obes Metab 2008;10:271-8. (Pubitemid 351386024)
    • (2008) Diabetes, Obesity and Metabolism , vol.10 , Issue.4 , pp. 271-278
    • Andrikoula, M.1    Mcdowell, I.F.W.2
  • 9
    • 46449096115 scopus 로고    scopus 로고
    • Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment
    • Kastelein JJ, van der Steeg WA, Holme I, et al. Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation 2008;117:3002-9.
    • (2008) Circulation , vol.117 , pp. 3002-3009
    • Kastelein, J.J.1    Van Der Steeg, W.A.2    Holme, I.3
  • 10
    • 34250208462 scopus 로고    scopus 로고
    • Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke
    • DOI 10.1097/HCO.0b013e3281bd8849, PII 0000157320070700000016
    • Walldius G, Jungner I. Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke. Curr Opin Cardiol 2007;22:359-67. (Pubitemid 46897289)
    • (2007) Current Opinion in Cardiology , vol.22 , Issue.4 , pp. 359-367
    • Walldius, G.1    Jungner, I.2
  • 11
    • 0031032472 scopus 로고    scopus 로고
    • ApoA-II/apoA-I molar ratio in the HDL particle influences phospholipid transfer protein-mediated HDL interconversion
    • Pussinen PJ, Jauhiainen M, Ehnholm C. ApoA-II/apoA-I molar ratio in the HDL particle influences phospholipid transfer protein-mediated HDL interconversion. J Lipid Res 1997;38:12-21. (Pubitemid 27097070)
    • (1997) Journal of Lipid Research , vol.38 , Issue.1 , pp. 12-21
    • Pussinen, P.J.1    Jauhiainen, M.2    Ehnholm, C.3
  • 12
    • 48149087776 scopus 로고    scopus 로고
    • HDL-cholesterol: Is it really good?: Differences between apoA-I and HDL
    • Santos-Gallego CG, Ibanez B, Badimon JJ. HDL-cholesterol: Is it really good?: Differences between apoA-I and HDL. Biochem Pharmacol 2008;76:443-52.
    • (2008) Biochem Pharmacol , vol.76 , pp. 443-452
    • Santos-Gallego, C.G.1    Ibanez, B.2    Badimon, J.J.3
  • 13
    • 33645422718 scopus 로고    scopus 로고
    • Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL
    • Zannis V, Chroni A, Krieger M. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. J Mol Med 2006;84:276-94.
    • (2006) J Mol Med , vol.84 , pp. 276-294
    • Zannis, V.1    Chroni, A.2    Krieger, M.3
  • 14
    • 80053390838 scopus 로고    scopus 로고
    • ApoE controls the interface linking lipids and inflammation in atherosclerosis
    • Weber C, Soehnlein O. ApoE controls the interface linking lipids and inflammation in atherosclerosis. J Clin Invest 2011;121:3825-7.
    • (2011) J Clin Invest , vol.121 , pp. 3825-3827
    • Weber, C.1    Soehnlein, O.2
  • 15
    • 77953518270 scopus 로고    scopus 로고
    • The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis
    • Zhang HL, Wu J, Zhu J. The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Dev Immunol 2010;2010:186813..
    • (2010) Clin Dev Immunol , vol.2010 , pp. 186813
    • Zhang, H.L.1    Wu, J.2    Zhu, J.3
  • 16
    • 84863504256 scopus 로고    scopus 로고
    • Apolipoprotein E and apolipoprotein E receptors: Normal biology and roles in Alzheimer disease
    • Holtzman DM, Herz J, Bu G. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med 2012;2:a006312.
    • (2012) Cold Spring Harb Perspect Med , vol.2
    • Holtzman, D.M.1    Herz, J.2    Bu, G.3
  • 17
    • 84869209204 scopus 로고    scopus 로고
    • Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: A longitudinal cohort study
    • Kalincik T, Vaneckova M, Tyblova M, et al. Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study. PloS ONE 2012;7:e50101.
    • (2012) PloS ONE , vol.7
    • Kalincik, T.1    Vaneckova, M.2    Tyblova, M.3
  • 18
    • 84872203150 scopus 로고    scopus 로고
    • Environmental factors associated with disease progression after the first demyelinating event: Results from the multi-center SET study
    • Horakova D, Zivadinov R, Weinstock-Guttman B, et al. Environmental factors associated with disease progression after the first demyelinating event: results from the multi-center SET study. PloS ONE 2013;8:e53996.
    • (2013) PloS ONE , vol.8
    • Horakova, D.1    Zivadinov, R.2    Weinstock-Guttman, B.3
  • 19
    • 80054106754 scopus 로고    scopus 로고
    • Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: A case-control study
    • Zivadinov R, Heininen-Brown M, Schirda CV, et al. Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study. NeuroImage 2012;59:331-9.
    • (2012) NeuroImage , vol.59 , pp. 331-339
    • Zivadinov, R.1    Heininen-Brown, M.2    Schirda, C.V.3
  • 20
    • 0036742197 scopus 로고    scopus 로고
    • Accurate, robust, and automated longitudinal and cross-sectional brain change analysis
    • Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. NeuroImage 2002;17:479-89.
    • (2002) NeuroImage , vol.17 , pp. 479-489
    • Smith, S.M.1    Zhang, Y.2    Jenkinson, M.3
  • 21
    • 79955484518 scopus 로고    scopus 로고
    • A Bayesian model of shape and appearance for subcortical brain segmentation
    • Patenaude B, Smith SM, Kennedy DN, et al. A Bayesian model of shape and appearance for subcortical brain segmentation. NeuroImage 2011;56:907-22.
    • (2011) NeuroImage , vol.56 , pp. 907-922
    • Patenaude, B.1    Smith, S.M.2    Kennedy, D.N.3
  • 22
    • 84883183367 scopus 로고    scopus 로고
    • Thalamic atrophy is associated with development of clinically definite multiple sclerosis
    • Zivadinov R, Havrdova E, Bergsland N, et al. Thalamic atrophy is associated with development of clinically definite multiple sclerosis. Radiology 2013;268:831-41.
    • (2013) Radiology , vol.268 , pp. 831-841
    • Zivadinov, R.1    Havrdova, E.2    Bergsland, N.3
  • 23
    • 34548124618 scopus 로고    scopus 로고
    • Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I - new risk factors and targets for therapy
    • DOI 10.1016/j.numecd.2007.02.010, PII S0939475307000567
    • Walldius G, Jungner I. Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I-new risk factors and targets for therapy. Nutr, Metab Cardiovasc Dis 2007;17:565-71. (Pubitemid 47302307)
    • (2007) Nutrition, Metabolism and Cardiovascular Diseases , vol.17 , Issue.8 , pp. 565-571
    • Walldius, G.1    Jungner, I.2
  • 25
    • 49049090627 scopus 로고    scopus 로고
    • Apolipoprotein E-mediated immune regulation in sepsis
    • Kattan OM, Kasravi FB, Elford EL, et al. Apolipoprotein E-mediated immune regulation in sepsis. J Immunol 2008;181:1399-408.
    • (2008) J Immunol , vol.181 , pp. 1399-1408
    • Kattan, O.M.1    Kasravi, F.B.2    Elford, E.L.3
  • 26
    • 84858423000 scopus 로고    scopus 로고
    • Reducing human apolipoprotein E levels attenuates age-dependent Abeta accumulation in mutant human amyloid precursor protein transgenic mice
    • Bien-Ly N, Gillespie AK, Walker D, et al. Reducing human apolipoprotein E levels attenuates age-dependent Abeta accumulation in mutant human amyloid precursor protein transgenic mice. J Neuroscience2012;32:4803-11.
    • (2012) J Neuroscience , vol.32 , pp. 4803-4811
    • Bien-Ly, N.1    Gillespie, A.K.2    Walker, D.3
  • 27
    • 33745584625 scopus 로고    scopus 로고
    • ApoE plasma levels and risk of cardiovascular mortality in old age
    • Mooijaart SP, Berbee JF, van Heemst D, et al. ApoE plasma levels and risk of cardiovascular mortality in old age. PLoS Med 2006;3:e176.
    • (2006) PLoS Med , vol.3
    • Mooijaart, S.P.1    Berbee, J.F.2    Van Heemst, D.3
  • 28
    • 84870262595 scopus 로고    scopus 로고
    • Closing the case of APOE in multiple sclerosis: No association with disease risk in over 29 000 subjects
    • Lill CM, Liu T, Schjeide BM, et al. Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects. J Med Genet 2012;49:558-62.
    • (2012) J Med Genet , vol.49 , pp. 558-562
    • Lill, C.M.1    Liu, T.2    Schjeide, B.M.3
  • 29
    • 33745043269 scopus 로고    scopus 로고
    • The association between apolipoprotein E and multiple sclerosis
    • DOI 10.1111/j.1468-1331.2006.01360.x
    • Pinholt M, Frederiksen JL, Christiansen M. The association between apolipoprotein E and multiple sclerosis. Eur J Neurol 2006;13:573-80. (Pubitemid 43873629)
    • (2006) European Journal of Neurology , vol.13 , Issue.6 , pp. 573-580
    • Pinholt, M.1    Frederiksen, J.L.2    Christiansen, M.3
  • 30
    • 0023205122 scopus 로고
    • Changes in cerebrospinal fluid IgG and apolipoprotein E indices in patients with multiple sclerosis during demyelination and remyelination
    • Rifai N, Christenson RH, Gelman BB, et al. Changes in cerebrospinal fluid IgG and apolipoprotein E indices in patients with multiple sclerosis during demyelination and remyelination. Clin Chem 1987;33:1155-7. (Pubitemid 17157906)
    • (1987) Clinical Chemistry , vol.33 , Issue.7 , pp. 1155-1157
    • Rifai, N.1    Christenson, R.H.2    Gelman, B.B.3    Silverman, L.M.4
  • 33
    • 0033943488 scopus 로고    scopus 로고
    • Apolipoprotein E (APOE) phenotype and APOE concentrations in multiple sclerosis and acute herpes zoster
    • DOI 10.1034/j.1600-0404.2000.102002094.x
    • Pirttila T, Haanpaa M, Mehta PD, et al. Apolipoprotein E (APOE) phenotype and APOE concentrations in multiple sclerosis and acute herpes zoster. Acta Neurol Scand 2000;102:94-8. (Pubitemid 30469502)
    • (2000) Acta Neurologica Scandinavica , vol.102 , Issue.2 , pp. 94-98
    • Pirttila, T.1    Haanpaa, M.2    Mehta, P.D.3    Lehtimaki, T.4
  • 34
    • 84873047379 scopus 로고    scopus 로고
    • Paradoxical effects of apolipoprotein E on cognitive function and clinical progression in mice with experimental autoimmune encephalomyelitis
    • Dayger CA, Rosenberg JS, Winkler C, et al. Paradoxical effects of apolipoprotein E on cognitive function and clinical progression in mice with experimental autoimmune encephalomyelitis. Pharmacol Biochem Behav 2013;103:860-8.
    • (2013) Pharmacol Biochem Behav , vol.103 , pp. 860-868
    • Dayger, C.A.1    Rosenberg, J.S.2    Winkler, C.3
  • 35
    • 79959340773 scopus 로고    scopus 로고
    • Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M
    • Christoffersen C, Obinata H, Kumaraswamy SB, et al. Endothelium- protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc Natl Acad Sci USA 2011;108:9613-8.
    • (2011) Proc Natl Acad Sci USA , vol.108 , pp. 9613-9618
    • Christoffersen, C.1    Obinata, H.2    Kumaraswamy, S.B.3
  • 37
    • 33846688688 scopus 로고    scopus 로고
    • FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice
    • DOI 10.1161/CIRCULATIONAHA.106.641407, PII 0000301720070130000013
    • Nofer JR, Bot M, Brodde M, et al. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2007;115:501-8. (Pubitemid 46188244)
    • (2007) Circulation , vol.115 , Issue.4 , pp. 501-508
    • Nofer, J.-R.1    Bot, M.2    Brodde, M.3    Taylor, P.J.4    Salm, P.5    Brinkmann, V.6    Van Berkel, T.7    Assmann, G.8    Biessen, E.A.L.9
  • 38
    • 79960341237 scopus 로고    scopus 로고
    • Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): A placebo-controlled randomised phase 4 trial
    • Sorensen PS, Lycke J, Eralinna JP, et al. Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial. Lancet Neurol 2011;10:691-701.
    • (2011) Lancet Neurol , vol.10 , pp. 691-701
    • Sorensen, P.S.1    Lycke, J.2    Eralinna, J.P.3
  • 39
    • 84860723016 scopus 로고    scopus 로고
    • Randomized controlled trial of atorvastatin in clinically isolated syndrome: The STAyCIS study
    • Waubant E, Pelletier D, Mass M, et al. Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study. Neurology 2012;78:1171-8.
    • (2012) Neurology , vol.78 , pp. 1171-1178
    • Waubant, E.1    Pelletier, D.2    Mass, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.